Two cases of refractory eosinophilic granulomatosis with polyangiitis wherein mepolizumab was effective against pulmonary and ear lesions.
ANCA-associated vasculitis
Eosinophilic granulomatosis with polyangiitis
lung lesions
mepolizumab
otitis media with ANCA-associated vasculitis
Journal
Modern rheumatology case reports
ISSN: 2472-5625
Titre abrégé: Mod Rheumatol Case Rep
Pays: England
ID NLM: 101761026
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
pubmed:
4
2
2021
medline:
1
12
2021
entrez:
3
2
2021
Statut:
ppublish
Résumé
Recently, mepolizumab, an interleukin (IL)-5 inhibitor, has been indicated for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) refractory to standard therapies. However, no reports have compared the efficacy of mepolizumab according to symptoms and organ lesions. Herein, we report two cases in which mepolizumab was highly effective in the management of EGPA with lung lesions and otitis media refractory to treatment with multiple immunosuppressive agents. These two cases suggest that mepolizumab is effective in treating pulmonary and ear lesions in EGPA.
Identifiants
pubmed: 33533698
doi: 10.1080/24725625.2021.1881205
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
mepolizumab
90Z2UF0E52
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM